ABBV — AI Stock Analysis & Recommendation

TradeFlare's AI research teams rate ABBV a BUY with a conviction of 72/100. The current price is $262.9.

• Entry: $256.1
• Target: $294.97
• Stop: $230.49

The technical setup suggests a potential breakout, and the fundamental and sentiment tailwinds are expected to play out over a few weeks. Catalysts to watch: Continued strong performance of Skyrizi and Rinvoq driving revenue growth; Positive sentiment surrounding the Apogee acquisition and pipeline strength; Potential for a technical breakout above current resistance levels. Key risks: High P/E ratio and negative equity position raise valuation concerns; Patent expirations and biosimilar competition for legacy products; Uncertainty surrounding the R&D pipeline and FDA decisions.

FlareScore breakdown — Technical: 70 · Fundamental: 60 · Sentiment: 75 · Risk: 30

Last updated August 27, 2026 · AI-generated analysis for informational purposes, not financial advice.